Biolase has reported revenue growth for its second quarter of the fiscal year (end-June 30, 2021).
The company said its net revenue was $9.1 million, a 211% increase over net revenue of $2.9 million in the same period of 2020. Net revenue was 6% higher than prepandemic revenue during the second quarter of 2019.
Company leaders credited the growth in part to rising demand for dental lasers as a result of the company's focus on education and training, as well as published studies of the laser's treatment of periodontal disease.
